Development and significance of zidovudine resistance in children infected with human immunodeficiency virus
- 31 July 1993
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 123 (1), 1-8
- https://doi.org/10.1016/s0022-3476(05)81529-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- HIV-1 sensitivity to zidovudine and clinical outcome in childrenThe Lancet, 1992
- p24 antigenaemia, CD4 lymphocyte counts and the development of AIDSAIDS, 1991
- A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus DiseaseNew England Journal of Medicine, 1991
- Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophiliaThe Journal of Pediatrics, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Decreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDSThe Journal of Infectious Diseases, 1990
- A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with HemophiliaNew England Journal of Medicine, 1989
- Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapyAIDS, 1989
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987